<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Surgical Sciences</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/57ED7729-987E-41D6-94D2-09167726D39E"><gtr:id>57ED7729-987E-41D6-94D2-09167726D39E</gtr:id><gtr:firstName>Kathryn</gtr:firstName><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800842"><gtr:id>F6354FA5-EC1B-486A-8A52-4868CCF26A97</gtr:id><gtr:title>Humanised mouse models</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800842</gtr:grantReference><gtr:abstractText>Transplantation can transform as well as save lives, but rejection remains a formidable barrier to long term success. The normal job of the immune system is to fight off infection, but in someone who has had a transplant it also tries to attack and destroy the transplant through the process known as rejection. To stop rejection, transplant recipients have to take a mixture of immunosuppressive drugs that inhibit the immune system. The doctors who take care of transplant recipients use their experience to perform a balancing act and get the amount of immunosuppression taken by each recipient just right, as taking too much can prevent the immune system from working altogether increasing the risk of infection; while taking too little increases the risk the transplant being lost to rejection. New and improved immunosuppressive drugs are required to enable transplants to survive for longer and to reduce the side effects experienced by transplant patients who have to take the drugs that are currently availability. This project will develop new models for use in transplantation research that will enable the discovery and development of novel therapies. If we are successful our research will speed up the introduction of new therapies into clinical transplantation and will have a major benefit for transplant recipients enabling them to have a functioning transplant for much longer.</gtr:abstractText><gtr:technicalSummary>Transplantation is the main therapy for patients with established organ failure, although the immune system remains a formidable barrier to successful long term outcomes. All transplant recipients are treated with a combination of immunosuppressive drugs, small molecules as well as biological agents, to try and prevent destruction of the graft, but delayed rejection still occurs. To improve long term outcomes in transplantation and to reduce the harmful side effects associated with current immunosuppression, therapeutic agents targeting novel pathways that contribute to the rejection process are required. 
In vitro systems cannot yet accurately recreate the complex microenvironments that exist in vivo within the transplant and lymphoid tissues of the recipient. While rodent and large animal transplant models are informative they have well recognised limitations. Therefore, there is a need to continue to develop, optimise and validate humanised mouse models for use in transplantation research to facilitate discovery and translation of novel therapeutic strategies for use in clinical transplantation. The aim of this project is to test the hypothesis that CD34+ selected cord blood progenitor cells will allow the development and validation of an improved humanised mouse model that can be used to investigate the cellular and molecular mechanisms of rejection elicited by human leukocytes as they respond to a human allograft in vivo and to determine the efficacy of novel therapies. Optimisation and validation of humanized mouse models for use in transplantation research will facilitate the development of new interventions for the prevention and treatment of transplant rejection.</gtr:technicalSummary><gtr:fund><gtr:end>2013-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>377618</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Milward, K., Hester, J, Issa, F. &amp; Wood, K.J. Neuropilin-1 is Required for Suppressive Function in Human Regulatory T Cells. British Society of Immunology &amp; Annual Congress, Liverpool, UK. Oral Presentation.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>36A4F01D-2407-491A-A964-C26677209022</gtr:id><gtr:impact>Presentation at the British Society of Immunology &amp;amp; Annual Congress</gtr:impact><gtr:outcomeId>58be9325079033.72866112</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Milward, K., Issa, F., Hester, J &amp; Wood, K.J. Humanised Mouse Models to Study Human Tregs. UK Humanised Mouse Symposium 2015, Cambridge, UK. Oral presentation.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9161B2C5-8407-4352-91D6-7932516F60A2</gtr:id><gtr:impact>Presentation at UK Humanised Mouse Symposium</gtr:impact><gtr:outcomeId>58be94038a5753.24352668</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Milward, K., Hester, J, &amp; Wood, K.J. Genetic Engineering of Human Regulatory T Cells. European Cooperation in Science &amp; Technology AFACTT Workshop 2016, London, U.K. Oral presentation.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B6BCEF6E-D958-4B90-A1BF-0842632468B0</gtr:id><gtr:impact>Presentation at the European Cooperation in Science &amp;amp; Technology AFACTT Workshop</gtr:impact><gtr:outcomeId>58be9378753e69.80810371</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RISET project dissemination</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>30DDA01E-4CE9-4ACE-80BC-FC381D09769E</gtr:id><gtr:impact>Leaflets published, final meeting of the RISET project held in the European Parliament, final report to the European Commission.

none noted</gtr:impact><gtr:outcomeId>pmvmRzhTrXR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Astellas Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>18161F1D-DEA1-44F3-ADBD-A5F1084E8728</gtr:id><gtr:impact>Seminar

None noted</gtr:impact><gtr:outcomeId>pbCBhcCzwnc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Colloquium on Organ Transplantation, Seoul Korea</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>808B9025-F3A0-44AC-8BF2-96409E370A02</gtr:id><gtr:impact>Presentation to international audience

dissemination of research</gtr:impact><gtr:outcomeId>GKX17ppivmQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Milward, K., Hester, J, Issa, F. &amp; Wood, K.J. Insights into Treg Biology from Genetic Engineering of Primary Human Tregs. British Society of Immunology Advanced Cell Therapy Symposium 2016, London, U.K. Oral presentation.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6D90FB2B-1244-4215-B633-1E455F4C86A6</gtr:id><gtr:impact>Presentation at the British Society of Immunology Advanced Cell Therapy Symposium</gtr:impact><gtr:outcomeId>58be93bfc127f1.17287924</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Transplantation Symposium, Zurich</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D8FFD4DB-6135-47BC-9A6A-2D5F411C6F2C</gtr:id><gtr:impact>Discussion and Questions

Dissemination of research, education for clinicians</gtr:impact><gtr:outcomeId>KpZpjHKUG5o</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation by Masaki Zaitsu at TTS Congress 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>452D87F3-816F-4029-B10E-20EA55CCF6C2</gtr:id><gtr:impact>Presentation by Dr Masaaki Zaitsu, who won the Mentee/Mentor Award, The Transplantation Society 2013 (with Prof Kathryn Wood)</gtr:impact><gtr:outcomeId>58be94f7422ee7.38427786</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting hosted by Miltenyi Biotech</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>41C62F9C-1D55-41D8-BE27-896882640741</gtr:id><gtr:impact>A two day scientific meeting attended by two of the group's senior postdoctoral researchers

None Noted</gtr:impact><gtr:outcomeId>PEJF78cJhJz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>La Scuola Superiore de Ruggero Ceppellini, Naples</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0DC568D8-4A53-4F7D-963E-C357F841F631</gtr:id><gtr:impact>Education

none noted</gtr:impact><gtr:outcomeId>ciu8Etsyphv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Immunocore Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>03B57FB0-17A8-4119-AD4D-FADC263DC9A0</gtr:id><gtr:impact>Seminar

None noted</gtr:impact><gtr:outcomeId>YFUKj4DgSUt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>228434</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Project Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>4FB778C8-24FD-47ED-8663-693B90A6C006</gtr:id><gtr:outcomeId>sU9dSfDLJAX0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>142279</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Union Marie Curie Intra European Fellowship</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>076EBBC5-FADE-44E6-A762-AB675673956B</gtr:id><gtr:outcomeId>BydndkomuVK0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>214546</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Research Training Fellowship</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3AA89C72-F1F3-4351-B4AB-A3D6D1B75C1B</gtr:id><gtr:outcomeId>R91UaAErC6N0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Garfield Weston Trust Project Grant</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Garfield Weston Foundation</gtr:fundingOrg><gtr:id>B475C488-505B-4FD7-B29F-8290C40AF044</gtr:id><gtr:outcomeId>krjEawGcAdz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1467996</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Programme Grant</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>8A850F6E-3B4D-4BCA-9627-8B17CB7E92D1</gtr:id><gtr:outcomeId>BfL5eaDYrEv0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Reseach Training Fellowship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>FE9641C5-378D-46DB-BE14-29F125EE0396</gtr:id><gtr:outcomeId>FDEpt3jA5YB0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>381520</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>European Union FP7</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>E12AF5C6-DB76-49F6-832A-27274517EC1E</gtr:id><gtr:outcomeId>fYKtRpSFsHP0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>161892</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>3F70E889-F382-466C-81BB-6B27EE648497</gtr:id><gtr:outcomeId>bKvrzZAAvhm0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>219536</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Training Fellowship</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9D3E6496-3293-419F-92EB-487EBBFA63C6</gtr:id><gtr:outcomeId>kHHbD5jGHzc0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1010000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>European Union FP7</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>356F15A9-E797-43DB-8B6E-23C5AF9E96FA</gtr:id><gtr:outcomeId>NUpLAibKzka0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>155646</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart Foundation Project Grant</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>3C4E0E9F-90B8-4B69-8130-CC0FE6AF6A3E</gtr:id><gtr:outcomeId>KGQmbGsrZB20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>185563</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Training Fellowship</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2F80B3F0-B0ED-461D-9477-542E047B08C9</gtr:id><gtr:outcomeId>QmyZ2amH3KR0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Transplanted tissue (allogeneic vessel and skin grafts) harvested at various times after transplantation prepared for histological analysis</gtr:description><gtr:id>79345863-BD41-4A71-B64D-4674A1176524</gtr:id><gtr:impact>Proof of concept data for the translation of regulatory T cell therapy to clinical transplantation</gtr:impact><gtr:outcomeId>Fe3mRb3c8jw</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Humanised mouse model for transplantation and stem cell research and clinical translation</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>45F744F2-3629-4F19-88B3-3B449297D307</gtr:id><gtr:title>Translating tolerogenic therapies to the clinic - where do we stand?</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a56ae3fbf526783f137e995a9ad8a834"><gtr:id>a56ae3fbf526783f137e995a9ad8a834</gtr:id><gtr:otherNames>Issa F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>pm_14137_27_22934094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B8E0AD2-6D3F-4477-AA33-1EB0671D1320</gtr:id><gtr:title>B cells with immune-regulating function in transplantation.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4eb32667d9311d5d3961c6d1f88f285d"><gtr:id>4eb32667d9311d5d3961c6d1f88f285d</gtr:id><gtr:otherNames>Stolp J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-5061</gtr:issn><gtr:outcomeId>56c6f69acebc28.76105344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB9C952F-B6A7-4E1C-908C-D5C5ABBBB64B</gtr:id><gtr:title>Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14137_27_23940349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AEF78BB-5F6E-4F98-88F8-CAD74444397A</gtr:id><gtr:title>CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a446f8ca4c63dcd2488a2582e7dd12dc"><gtr:id>a446f8ca4c63dcd2488a2582e7dd12dc</gtr:id><gtr:otherNames>Bottomley MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>56c6f87c4495b4.65563553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77FB703A-F793-4153-A98E-0731315F786B</gtr:id><gtr:title>Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions?</gtr:title><gtr:parentPublicationTitle>Transplant international : official journal of the European Society for Organ Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a463567ebd4ce771d0725fffe28c5e2"><gtr:id>5a463567ebd4ce771d0725fffe28c5e2</gtr:id><gtr:otherNames>Chandrasekharan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0934-0874</gtr:issn><gtr:outcomeId>pm_14137_27_23517251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A099C0CD-0623-4FDF-8E76-D25A5B314806</gtr:id><gtr:title>Moving to tolerance: clinical application of T regulatory cells.</gtr:title><gtr:parentPublicationTitle>Seminars in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e0a54be42e1be67a7685ac88e573443"><gtr:id>3e0a54be42e1be67a7685ac88e573443</gtr:id><gtr:otherNames>McMurchy AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1044-5323</gtr:issn><gtr:outcomeId>pm_14137_27_21620722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90AEDEBC-C725-4B2E-A1BF-92A785709D34</gtr:id><gtr:title>In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ca6e5876ac26ec815bdf70f3968aab5"><gtr:id>1ca6e5876ac26ec815bdf70f3968aab5</gtr:id><gtr:otherNames>Nadig SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>hTtCDMLuc8s</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C285249B-8910-418D-BCC9-CE13F739765E</gtr:id><gtr:title>Immunogenicity of embryonic stem cell-derived progenitors after transplantation.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35673fa19257cbfd66aafd869ca9695e"><gtr:id>35673fa19257cbfd66aafd869ca9695e</gtr:id><gtr:otherNames>English K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>pm_14137_27_21150615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>221A5262-E3E9-406A-ADFD-F169AFEEF91F</gtr:id><gtr:title>CD4+ regulatory T cells in solid organ transplantation.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a56ae3fbf526783f137e995a9ad8a834"><gtr:id>a56ae3fbf526783f137e995a9ad8a834</gtr:id><gtr:otherNames>Issa F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>pm_14137_27_20881492</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9ECDE897-D71A-4713-BDD4-805800A45442</gtr:id><gtr:title>Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90bd46e23fdf0d2d0c63c656908dcd37"><gtr:id>90bd46e23fdf0d2d0c63c656908dcd37</gtr:id><gtr:otherNames>Wood KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>pm_14137_27_21488894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>524FEE9B-DF68-40C1-ABCC-7540D8ACCBFB</gtr:id><gtr:title>Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed82a801810eb941b10862aff3b1113"><gtr:id>8ed82a801810eb941b10862aff3b1113</gtr:id><gtr:otherNames>Feng G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>pm_14137_27_21593400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF153ED6-79D7-400D-873C-3ED822C805D2</gtr:id><gtr:title>Ischemia-reperfusion injury accelerates human antibody-mediated transplant vasculopathy.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2da765888c99f65aa7d8fdcfdc0f98eb"><gtr:id>2da765888c99f65aa7d8fdcfdc0f98eb</gtr:id><gtr:otherNames>Goto R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>pm_14137_27_23856999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>066162F2-61B7-43BF-8F3B-DA562A1B5087</gtr:id><gtr:title>Bystander activation of iNKT cells occurs during conventional T-cell alloresponses.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b82391780be83628fc99fe5451faae5"><gtr:id>0b82391780be83628fc99fe5451faae5</gtr:id><gtr:otherNames>Jukes JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>pm_14137_27_22070799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82402BAA-4619-4D0E-B180-4EC4768E78EC</gtr:id><gtr:title>Delayed anti-CD3 therapy results in depletion of alloreactive T cells and the dominance of Foxp3+ CD4+ graft infiltrating cells.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2da765888c99f65aa7d8fdcfdc0f98eb"><gtr:id>2da765888c99f65aa7d8fdcfdc0f98eb</gtr:id><gtr:otherNames>Goto R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>pm_14137_27_23750800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49367FF2-9F48-4070-A84C-25621748277C</gtr:id><gtr:title>The potential role for regulatory T-cell therapy in vascularized composite allograft transplantation.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a56ae3fbf526783f137e995a9ad8a834"><gtr:id>a56ae3fbf526783f137e995a9ad8a834</gtr:id><gtr:otherNames>Issa F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>56c6fa9876e004.47851381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B065CE46-3885-4DDE-91E6-6B4CC5FE45CC</gtr:id><gtr:title>Costimulation blockade: current perspectives and implications for therapy.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9592519499f120d5dfa612edcd06fef1"><gtr:id>9592519499f120d5dfa612edcd06fef1</gtr:id><gtr:otherNames>Kinnear G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>pm_14137_27_23129000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D416C69-DDB6-4279-AD47-D8422B493070</gtr:id><gtr:title>Induction of transplantation tolerance through regulatory cells: from mice to men.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32441189f9f691625f1945bcd5308096"><gtr:id>32441189f9f691625f1945bcd5308096</gtr:id><gtr:otherNames>Ferrer IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>56c6f672551eb7.32533699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC413768-D16C-42C5-96BF-F559CFE90DFD</gtr:id><gtr:title>The where and when of T cell regulation in transplantation.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a56ae3fbf526783f137e995a9ad8a834"><gtr:id>a56ae3fbf526783f137e995a9ad8a834</gtr:id><gtr:otherNames>Issa F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>pm_14137_27_23228885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5383D06-CED2-4E30-8764-68A47D346738</gtr:id><gtr:title>Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance?</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/024ee6c5e746a914b5ba12cc38e1aaa5"><gtr:id>024ee6c5e746a914b5ba12cc38e1aaa5</gtr:id><gtr:otherNames>Chadha R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>pm_14137_27_21378605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFE0CCEB-AFDA-4434-A351-3549578FCA7B</gtr:id><gtr:title>Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.</gtr:title><gtr:parentPublicationTitle>Transplantation direct</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a446f8ca4c63dcd2488a2582e7dd12dc"><gtr:id>a446f8ca4c63dcd2488a2582e7dd12dc</gtr:id><gtr:otherNames>Bottomley MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2373-8731</gtr:issn><gtr:outcomeId>5a830626c1f905.24661754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D11AA7C6-E78D-4025-B689-234D02D535D6</gtr:id><gtr:title>Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a56ae3fbf526783f137e995a9ad8a834"><gtr:id>a56ae3fbf526783f137e995a9ad8a834</gtr:id><gtr:otherNames>Issa F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14137_27_23300911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C5C88B8-EF79-4C60-80CE-1DB186FE2C17</gtr:id><gtr:title>Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b263c650ef71d22018d2735b0ca111d1"><gtr:id>b263c650ef71d22018d2735b0ca111d1</gtr:id><gtr:otherNames>Milward K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>pm_14137_27_23263503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC726D40-B10C-4CD0-8DA1-958F295E2E3B</gtr:id><gtr:title>A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9592519499f120d5dfa612edcd06fef1"><gtr:id>9592519499f120d5dfa612edcd06fef1</gtr:id><gtr:otherNames>Kinnear G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14137_27_23817421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94E2FDC3-FFAF-4444-BCC2-ED7C0B42483D</gtr:id><gtr:title>Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b487780c988a09ea743229f8325c3ff2"><gtr:id>b487780c988a09ea743229f8325c3ff2</gtr:id><gtr:otherNames>Hester J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>pm_14137_27_21412187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5292623-4D70-4A56-95D8-CE0F9DA20ADA</gtr:id><gtr:title>The impact of Th17 cells on transplant rejection and the induction of tolerance.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56a828c6a79e3a83d23e04f8944e4cf1"><gtr:id>56a828c6a79e3a83d23e04f8944e4cf1</gtr:id><gtr:otherNames>Heidt S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>EAB4973D_CEAB4973D_C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D7007ED-9614-4D3B-9C7B-6B1D2587A00A</gtr:id><gtr:title>Ly-6C(hi) monocytes: a potential target for preventing transplant arteriosclerosis?</gtr:title><gtr:parentPublicationTitle>Expert review of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26f3c6e3973e5e8f9e559ad2cdbfebf9"><gtr:id>26f3c6e3973e5e8f9e559ad2cdbfebf9</gtr:id><gtr:otherNames>Schiopu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1744-666X</gtr:issn><gtr:outcomeId>pm_14137_27_23256758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF6FD618-902F-4991-989C-E60D54DB9352</gtr:id><gtr:title>Mechanisms of rejection: current perspectives.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90bd46e23fdf0d2d0c63c656908dcd37"><gtr:id>90bd46e23fdf0d2d0c63c656908dcd37</gtr:id><gtr:otherNames>Wood KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>pm_14137_27_22138818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3015A570-7065-4FAF-96B1-6A9C00FAE3C9</gtr:id><gtr:title>Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a56ae3fbf526783f137e995a9ad8a834"><gtr:id>a56ae3fbf526783f137e995a9ad8a834</gtr:id><gtr:otherNames>Issa F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>V1dkgFZgjxk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC9F1802-C759-4280-AE51-8E4FD4213E29</gtr:id><gtr:title>Mesenchymal stromal cells in transplantation rejection and tolerance.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35673fa19257cbfd66aafd869ca9695e"><gtr:id>35673fa19257cbfd66aafd869ca9695e</gtr:id><gtr:otherNames>English K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>pm_14137_27_23637312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50BC09FC-4D5D-4242-9F09-5759F5A1F874</gtr:id><gtr:title>Regulatory T cells as modulators of chronic allograft dysfunction.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a56ae3fbf526783f137e995a9ad8a834"><gtr:id>a56ae3fbf526783f137e995a9ad8a834</gtr:id><gtr:otherNames>Issa F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>pm_14137_27_21752619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>835FFD4A-12A5-4D33-A11D-A0BA3C45D870</gtr:id><gtr:title>Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a9fb862836aff6b321abf7065703c03"><gtr:id>8a9fb862836aff6b321abf7065703c03</gtr:id><gtr:otherNames>Fuchs A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a830af1de8d93.32588430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DD7AD63-60FA-412A-9DF4-2DD8C5470DC5</gtr:id><gtr:title>Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b487780c988a09ea743229f8325c3ff2"><gtr:id>b487780c988a09ea743229f8325c3ff2</gtr:id><gtr:otherNames>Hester J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>pm_14137_27_22500984</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800842</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>